RAD51C and ovarian cancer: The small number of PALB2 mutations limits interpretation; however, RAD51C, RAD51D, and BRIP1 mutations were associated with both high rates of biallelic loss and high GIS, suggesting that these genes might be true drivers of HRD in ovarian cancer.